Solid Biosciences Inc

NASDAQ:SLDB  
1.69
-0.08 (-4.52%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)143.88M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.24 Million
Adjusted EPS-$0.20
See more estimates
10-Day MA$1.84
50-Day MA$2.16
200-Day MA$3.86
See more pivots

Solid Biosciences Inc Stock, NASDAQ:SLDB

141 Portland Street, 5th floor, Cambridge, Massachusetts 02139
Phone: +1.617.337.4680
Number of Employees: 70

Description

Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy (DMD). It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA.